more energy on semaglutide Does Make You Tired? Understanding Side Effects Benefits of Semaglutide GLP-1 in

Arizona OPEN ACCESS PUBLISHED:30 October 2024 CITATION:Chakkera, S

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and focusing on nutrient-dense, portion-controlled products.

This review highlights key clinical considerations across reproductive stages, emphasizes the primacy of human exposure data where available, and identifies critical evidence gaps requiring future prospective study.

Key changes every healthcare professional should know: Obesity is formally treated as a chronic, relapsing disease Lifestyle intervention remains essential, but anti-obesity medications are now considered a core component of care, not a last resort

Keep reading to learn more!

Recent estimates suggest that around 1.6 million adults used GLP-1 weight-loss drugs between early 2024 and early 2025, while broader data indicates up to 1.5 million people are currently taking them at any one time1